Should living-unrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial.
D001741:Black or African American / Q000706:statistics & numerical data; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D015331:Cohort Studies; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation / Q000208:ethnology; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012306:Risk; D013997:Time Factors
D000961:Antilymphocyte Serum